>>HomeContemporary issues



Aktuelle TZDOnews

Contemporary issues

Chimera Biotech receives the European Frost & Sullivan Award 2008 for the Imperacer

With a unique value proposition in the drug development and diagnostic markets, Chimera's innovative Imperacer® products and services have experienced widespread market acceptance.

“Imperacer® has a proven record for quantifying low-abundant proteins, peptides, biomarkers and a range of “difficult to quantify” markers”, says Mark Spengler, Product Manager at Chimera Biotec. “Among others Imperacer® is currently being used in fields like Alzheimer’s, rheumatoid arthritis, cardiovascular and cancer.”

Read the full press release of Chimera Biotec here.



Events

Training events and business breakfasts are provided to the tenants at frequent intervals. At least twice a month specialists for certain topics – such as lawyers, consultants or business economists – are invited in order to give qualified information to the mostly technical orientated young companies.

The full range of events you only find on the  German site.

This is just one of the services which our satisfied tenants profit from.